Study Finds Acute Normovolemic Hemodilution Used in Only 14.7% of Eligible Cardiac Surgeries in U.S.

A recent study conducted by the University of Oklahoma, published on September 3 in *JAMA Surgery*, reveals that acute normovolemic hemodilution (ANH), a blood conservation technique used during cardiac surgery, is significantly underutilized in the United States. The research indicates that only 14.7% of eligible procedures currently employ this method, despite findings showing that ANH reduces the likelihood of requiring a blood transfusion during heart surgery by 27%. This reduction has potential implications for lowering healthcare costs while maintaining patient safety and surgical outcomes.

ANH involves collecting a patient’s blood before initiating heart-lung bypass and reinfusing it near the conclusion of the procedure. By minimizing reliance on donor blood, this technique offers both clinical and economic benefits. The study highlights its effectiveness in reducing transfusion rates, which are associated with higher costs and potential risks to patients. Despite these advantages, researchers note its limited adoption across U.S. hospitals. The findings suggest an opportunity to expand the use of ANH to improve resource utilization without compromising care quality.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: The formatted date is: September 3, 2025

Author

Mark Chiang